Irinotecan hydrochloride trihydrate CAS NO.136572-09-3
| inoa | Irinotecan hydrochloride trihydrate | ||
| CAS NO. | 136572-09-3 | ||
| ʻĀpana Molekala | C33H45ClN4O9 | Kaumaha Molecular | 677.18 |
| MDL No. | MFCD01765731 | EINECS | 603-967-2 |
| MP | 250-256°C (Dek.) | BP | 257°C(māmā) |
| ʻO ka mānoanoa | NA | Hōʻike Hōʻike | NA |
| FP | NA | Kūlana mālama | 2-8°C |
| Ka nana aku | keʻokeʻo a melemele paʻa | ||
| Maemae | 98% | ||
| Palapala noi | Hiki ke hoʻohana ʻia ʻo Irinotecan hydrochloride trihydrate no ka hoʻomākaukau ʻana i nā injections a hoʻohana nui ʻia e mālama i nā ʻōpū o ka digestive system e like me ka maʻi maʻi ʻōpū, ka maʻi maʻi colon, ka maʻi maʻi rectal, ka maʻi maʻi ʻāʻī, etc.ʻO Irinotecan kahi mea hoʻololi kemika o ka camptothecin maoli. | ||
| Hiki ke hoolako | ʻO Irinotecan hydrochloride trihydrate CAS NO.136572-09-3 kā mākou huahana hana maʻamau, inā makemake ʻoe i kahi liʻiliʻi liʻiliʻi a i ʻole ka ukana nui i ʻoi aku ma mua o ka tonnage, hiki i kā mākou hui ke hoʻolako maʻamau. | ||
| Inā makemake ʻoe iā Irinotecan hydrochloride trihydrate CAS NO.136572-09-3, e ʻoluʻolu e leka uila mai iā mākou, a e hāʻawi mākou iā ʻoe i nā huahana maikaʻi loa, ke kumukūʻai kūpono a me ka lawelawe maikaʻi loa, e kali ana i kā mākou hui. | |
| | |
| Kelepona No. | +86 139 6251 3054 +86 136 2174 3828 |
ʻO nā huahana i heluʻia e ka hui e pili ana i nā patents, kahi wale nō no ka noiʻi a me ka hoʻomohalaʻana aʻaʻole no ke kūʻai aku;e kūʻai ʻia aku nā huahana i hoʻopaʻa ʻia e like me nā kānāwai Kina a me nā kānāwai o ka ʻāina i kūʻai ʻia ai lākou, a ʻaʻole kūpono nā huahana a pau no ka hoʻohana kanaka.Inā kūʻai ʻia, e lilo lākou i ʻāina hōʻino patent, na ka mea kūʻai aku e lawe i nā pilikia pili.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
![(S)-3-Phenyl-2-[(Pyrazin-2-Ylcarbonyl)Amino] Propanoic Acid CAS NO.114457-94-2](http://cdn.globalso.com/shlzpharma/114457-94-2-1.jpg)
